Oct 16, 2014 – A Dutch court on Thursday refused to punish two cannabis growers, criticising a government policy that criminalises the drug’s production while allowing its sale in coffee shops. “The court finds the suspects guilty,” the court in northern city Groningen said in its judgement, but “no punishment will be applied”. Owners of the Netherlands’ hundreds of coffee shops, where you can buy up to five grammes (around a sixth of an ounce) of marijuana over the counter, frequently criticise what they say is hypocritical legislation that forces them to buy the drug wholesale from criminals. “Given that…
Author: WebTeam
October 10, 2014 | Israeli researchers will soon begin evaluating the anti-tumor effects of cannabidiol, a nonpsychotropic cannabinoid, in patients with cancer. Researchers at the Hassadah Medical Center in Jerusalem have announced their intent to conduct a Phase II clinical trial to assess the impact of CBD as single treatment among cancer patients. Only patients who have exhausted conventional anti-cancer treatments will be eligible to participate in the study. Once enrolled in the trial, participants will receive CBD for a period of eight weeks. Full details of the forthcoming trial are available online from clinicaltrials.gov here. Although data documenting the…
Activation of the body’s cannabinoid receptors – which is done naturally through the consumption of cannabis – may promote bone formation and reduce bone dissolution, according to a study published this month in the journal Molecular and Cellular Biochemistry, and published online by the U.S. National Institute of Health. “The type-2 cannabinoid receptor (CB2) is expressed in osteoblasts and plays a role in bone metabolism through regulation on bone mass and bone turnover”, begins the study’s abstract; “but the functional importance of CB2 in osteoblasts under Titanium (Ti) stimulation is incompletely understood.” For the study, researchers “aimed to investigate the…
Cannabis, and the cannabinoid compounds found within it, has been shown through a large amount of scientific, peer-reviewed research to be effective at treating a wide variety of cancers, ranging from brain cancer to colon cancer. Below is a list of over 60 studies that demonstrate the vast anti-cancer properties of cannabis. Studies showing cannabis may combat brain cancer: Cannabidiol (CBD) inhibits the proliferation and invasion in U87-MG and T98G glioma cells. Study published in the Public Library of Science journal in October 2013. Tetrahydrocannabinol (THC) can kill cancer cells by causing them to self-digest. Study published in the Journal…
October 4, 2014 | Scientific revelations are published almost daily in regard to the healing properties of the cannabis. But most of these findings appear solely in obscure, peer-reviewed journals and go largely unnoticed by the major media. Here are five new cannabis-centric studies that warrant mainstream attention. Marijuana Use Is Associated With Decreased Mortality In TBI PatientsTraumatic brain injury (TBI) patients with a history of cannabis use possess increased survival rates compared to non-users, according data published this month in the journal American Surgeon. UCLA Medical Center investigators conducted a three-year retrospective review of brain trauma patients. Data from…
A new study published by the Oxford journal Carcinogenesis, and published online by the U.S. National Institute of Health, has found that the cannabis compound cannabigerol can prevent the progression of cancer cells formed in the colon.“Cannabigerol (CBG) is a safe non-psychotropic Cannabis-derived cannabinoid which interacts with specific targets involved in carcinogenesis [the creation of cancer cells]“, begins the study’s abstract. “Here, we investigated whether CBG protects against colon tumorigenesis.” After studying the effect of CBG on colon cancer cells, researchers found that; “In vivo, CBG inhibited the growth of xenograft tumors as well as chemically-induced colon carcinogenesis. CBG hampers colon…
Ribeirão Preto, Brazil: The administration of cannabidiol (CBD), a nonpsychotropic cannabinoid, is associated with improved quality of life in patients with Parkinson’s disease, according clinical trial data published online ahead of print in the Journal of Psychopharmacology.Investigators at the University of São Paulo in Brazil assessed the efficacy of CBD versus placebo in 21 subjects with Parkinson’s. Authors reported that the administration of 300 mg doses of CBD per day was associated with “significantly different mean total scores” in subjects’ well-being and quality of life compared to placebo. Separate assessments of CBD versus placebo reported that the cannabinoid did not appear…
The presence of tetrahydrocannabinol (THC) in the system is associated with increased survival rates in those who experience traumatic brain injury (TBI), according to a new study published in the American Journal of Surgery.“Traumatic brain injury (TBI) is associated with significant morbidity and mortality”, says Dr. Binh Minh Nguyen, the study’s lead author. “Several studies have demonstrated neuroprotective effects of cannabinoids. The objective of this study was to establish a relationship between the presence of a positive toxicology screen for tetrahydrocannabinol (THC) and mortality after TBI.” After examining 446 individuals – 18.4% of which had THC in their system – it…
A study published this month by the journal Cell Biochemistry and Function, and published online by the U.S. National Institute of Health, has found promising evidence to suggest that delta-9-tetrahydrocannabinol (THC) may provide a safe and effective treatment option for those with diabetes. For the study; “Rats were randomly divided into four groups: control, Δ9 -THC, diabetes and diabetes + Δ9 -THC groups. Δ9 -THC was administered intraperitoneally [through injection] at 3 mg/kg/day for 7 days. Body weights and blood glucose level of rats in all groups were measured on days 0, 7, 14 and 21.” Researchers found that treatment with THC “significantly increased pancreas…
A groundbreaking clinical trial may provide some answers to medical marijuana as a seizure treatment For years, some parents have turned to medical marijuana to treat their children’s debilitating epilepsy, crediting the drug with dramatically reducing seizure activity. A groundbreaking clinical trial about to begin recruiting test subjects may finally provide some science to back their claims. In what is believed to be the first study of its kind, researchers at the University of Colorado Anschutz Medical Campus will study the genes of those with a kind of epilepsy called Dravet Syndrome who have been treated with a strain of…
